Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Lung|September 15, 2014
The influence of mtDNA deletion on lung cancer cells under the conditions of hypoxia and irradiationCheng-Bo Han, Li Sun, Jie-Tao Ma, et al.
World Journal of Gastroenterology|December 21, 2004
Mutations of mitochondrial 12S rRNA in gastric carcinoma and their significanceCheng-Bo Han, Jia-Ming Ma, Yan Xin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 27, 2023
Dual antitumor immunomodulatory effects of PARP inhibitor on the tumor microenvironment: A counterbalance between anti-tumor and pro-tumorXiao-Fang Yi, Ruo-Lin Gao, Li Sun, et al.
Cancer Medicine|July 13, 2019
Rational application of the first-line chemotherapy and immune checkpoint inhibitors in advanced nonsmall cell lung cancer: A meta-analysisRui Cao, Jie-Tao Ma, Shu-Ling Zhang, et al.
Biomed Research International|February 12, 2021
Rational Application of First-Line EGFR-TKIs Combined with Antiangiogenic Inhibitors in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A Systematic Review and Meta-AnalysisJie-Tao Ma, Yi-Jia Guo, Jun Song, et al.
Journal of Cancer|August 17, 2019
Effects of Dynamin-related Protein 1 Regulated Mitochondrial Dynamic Changes on Invasion and Metastasis of Lung Cancer CellsJie-Tao Ma, Xiang-Yan Zhang, Rui Cao, et al.
Molecular Cancer|November 20, 2024
Targeting mitochondria: restoring the antitumor efficacy of exhausted T cellsMei-Qi Yang, Shu-Ling Zhang, Li Sun, et al.
Frontiers in Pharmacology|August 29, 2022
Efficacy and safety of combined immunotherapy and antiangiogenesis with or without chemotherapy for advanced non-small-cell lung cancer: A systematic review and pooled analysis from 23 prospective studiesRuo-Lin Gao, Jun Song, Li Sun, et al.
Frontiers in Oncology|January 21, 2020
Durable Clinical Response to Pyrotinib After Resistance to Prior Anti-HER2 Therapy for HER2-Positive Advanced Gastric Cancer: A Case ReportLe-Tian Huang, Jie-Tao Ma, Shu-Ling Zhang, et al.
Frontiers in Oncology|July 5, 2022
Efficacy of Osimertinib in EGFR-Mutated Advanced Non-small-Cell Lung Cancer With Different T790M Status Following Resistance to Prior EGFR-TKIs: A Systematic Review and Meta-analysisXiao-Fang Yi, Jun Song, Ruo-Lin Gao, et al.
Pageof 5